Article
Role of dopaminergic mechanisms in the stimulatory effects of MK-801 injected into the ventral tegmental area and the nucleus accumbens

https://doi.org/10.1016/0091-3057(95)02220-1Get rights and content

Abstract

The bilateral administration of 10μg of (+)MK-801, but not (−)MK-801, into either the VTA or the N.Ac. stimulated locomotor activity. The stimulation induced by (+)MK-801 at both sites was inhibited by reserpine (5 mg/kg, SC) and the D1 antagonist, SCH 23390 (0.1 mg/kg, SC). Eticlopride (0.03 mg/kg, SC), a D2 antagonist, inhibited the stimulation produced by MK-801 in the VTA but not in the N.Ac. Baclofen (32 ng), a GABAB receptor agonist, injected into the VTA inhibited the stimulatory response to MK-801 injected systemically, into the VTA, or into the N.Ac., but did not significantly inhibit spontaneous locomotion or the stimulatory response to apomorphine (5 mg/kg, SC). These observations suggest that the stimulatory effects of MK-801 in the VTA and the N.Ac. are dependent on endogenous dopamine. In addition, the effects produced by MK-801 injected into the VTA closely resemble those produced by the systemic administration of low doses of MK-801, suggesting that this is the primary site of action of MK-801.

References (45)

  • V. Seutin et al.

    Effect of dopamine and baclofen on N-methyl-D-aspartate-induced burst firing in rat ventral tegmental neurons

    Neuroscience

    (1994)
  • T. Tanner

    GABA-induced locomotor acivity in the rat after bilateral injection into the ventral tegmental area

    Neuropharmacology

    (1979)
  • M.D. Tricklebank et al.

    The behavioral effect of MK-801: A comparison with antagonists acting noncompetitively and competitively at the NMDA receptor

    Eur. J. Pharmacol.

    (1989)
  • T. Wang et al.

    Effects of phencyclidine on spontaneous and excitatory amino acid-induced activity of ventral tegmental dopamine neurons: An extracellular in vitro study

    Life Sci.

    (1993)
  • T. Wang et al.

    N-methyl-D-aspartic acid biphasically regulates the biochemical and electrophysiological response of A10 dopamine neurons in the ventral tegmental area: In vivo microdialysis and in vitro electrophysiological studies

    Brain Res.

    (1994)
  • D.L. Willins et al.

    The role of dopamine and AMPA/kainate receptors in the nucleus accumbens in the hypermotility response to MK-801

    Pharmacol. Biochem. Behav.

    (1993)
  • J. Zhang et al.

    Electrophysiological effects of MK-801 on rat nigrostriatal and mesoaccumbal dopaminergic neurons

    Brain Res.

    (1992)
  • K.D. Beck et al.

    Tyrosine hydroxylase mRNA expression by dopaminergic neurons in culture: Effect of 1-methyl-4-phenylpyridinium treatment

    J. Neurochem.

    (1991)
  • A. Bertler

    Effect of reserpine on the storage of catecholamines in the brain

    Acta Physiol. Scand.

    (1961)
  • G.R. Breese et al.

    Dopamine-agonist induced locomotor activity in rats treated with 6-hydroxy-dopamine at differing ages: Functional supersenstivity of D1 dopamine receptors in neonatally lesioned rats

    J. Pharmacol. Exp. Ther.

    (1985)
  • M. Carlsson et al.

    The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice

    J. Neural Transm.

    (1989)
  • M. Carlsson et al.

    Dramatic synergism between MK-801 and clonidine with respect to locomotor stimulatory effect in monoamine-depleted mice

    J. Neural Transm.

    (1989)
  • Cited by (59)

    • Modulation of brain stimulation reward and locomotor activity by ionotropic glutamate receptors of the tail of the ventral tegmental area

      2020, Behavioural Brain Research
      Citation Excerpt :

      Consistently, pharmacological activation of NMDA and AMPA glutamate receptors in the VTA increases mesolimbic DA release [17,18] and exploratory motor behavior [19] in rodents. However, other studies have reported increased DA release and burst firing of DA neurons [20,21], as well as enhanced locomotor activity [22,23] following blockade of VTA NMDA or AMPA receptors, suggesting an opposite modulatory role of glutamate on DA neuronal activity. Prior reports from our group have also shown that blockade of VTA NMDA receptors enhances the rewarding effect obtained through intracranial self-stimulation (ICSS), a phenomenon also termed brain stimulation reward [24–26], whereas the opposite effect is observed following blockade of VTA AMPA receptors [25].

    • Medial septum modulates hippocampal gamma activity and prepulse inhibition in an N-methyl-D-aspartate receptor antagonist model of schizophrenia

      2018, Schizophrenia Research
      Citation Excerpt :

      Positive modulation of hippocampal GABAB receptors may normalize the firing of hippocampal interneurons that are dis-excited by NMDAR blockade (Grunze et al., 1996), and thus normalize hippocampal gamma activity. However, other than the hippocampus, it is likely that a systemic GABAB receptor PAM normalize PPI and other psychosis-relevant behaviors by acting on GABAB receptors in different parts of the brain, including the pedunculopontine nucleus (PPN; Arai et al., 2008), prefrontal cortex (Fejgin et al., 2009), thalamus (Zhang et al., 2012), and ventral tegmental area (Erhardt et al., 2002) and NAc (Hunt et al., 2010; Narayan et al., 1996). How aberrant hippocampal gamma activity affects PPI and behavioral hyperactivity is not clearly known.

    • Ketamine Mediates Psychosis through the Medial Septum, Hippocampus, and Nucleus Accumbens

      2016, Neuropathology of Drug Addictions and Substance Misuse
    View all citing articles on Scopus
    View full text